vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and HERC HOLDINGS INC (HRI). Click either name above to swap in a different company.

HERC HOLDINGS INC is the larger business by last-quarter revenue ($30.1M vs $16.1M, roughly 1.9× Fortress Biotech, Inc.). Fortress Biotech, Inc. runs the higher net margin — -24.5% vs -331.7%, a 307.2% gap on every dollar of revenue. On growth, HERC HOLDINGS INC posted the faster year-over-year revenue change (629.3% vs 6.3%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Herc Holdings Inc. is a leading North American equipment rental service provider. It offers rental assets including heavy construction machinery, power tools, temporary power and climate control systems, serving clients across construction, industrial, events, infrastructure and government segments, with operations across the U.S. and Canada.

FBIO vs HRI — Head-to-Head

Bigger by revenue
HRI
HRI
1.9× larger
HRI
$30.1M
$16.1M
FBIO
Growing faster (revenue YoY)
HRI
HRI
+623.0% gap
HRI
629.3%
6.3%
FBIO
Higher net margin
FBIO
FBIO
307.2% more per $
FBIO
-24.5%
-331.7%
HRI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
HRI
HRI
Revenue
$16.1M
$30.1M
Net Profit
$-3.9M
$-99.9M
Gross Margin
66.1%
42.3%
Operating Margin
-28.8%
-77.4%
Net Margin
-24.5%
-331.7%
Revenue YoY
6.3%
629.3%
Net Profit YoY
41.8%
-866.2%
EPS (diluted)
$-0.15
$-0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
HRI
HRI
Q4 25
$16.1M
$30.1M
Q3 25
$17.6M
$10.1M
Q2 25
$16.4M
$6.3M
Q1 25
$13.1M
$4.2M
Q4 24
$15.1M
$4.1M
Q3 24
$14.6M
Q2 24
$14.9M
Q1 24
$13.0M
Net Profit
FBIO
FBIO
HRI
HRI
Q4 25
$-3.9M
$-99.9M
Q3 25
$5.8M
$-7.5M
Q2 25
$15.5M
$-10.8M
Q1 25
$-10.6M
$-14.1M
Q4 24
$-6.8M
$-10.3M
Q3 24
$-12.9M
Q2 24
$-10.9M
Q1 24
$-15.4M
Gross Margin
FBIO
FBIO
HRI
HRI
Q4 25
66.1%
42.3%
Q3 25
67.4%
25.8%
Q2 25
69.9%
53.1%
Q1 25
63.5%
35.0%
Q4 24
69.1%
21.4%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
HRI
HRI
Q4 25
-28.8%
-77.4%
Q3 25
-38.6%
-153.5%
Q2 25
-222.2%
-147.4%
Q1 25
-169.9%
-242.7%
Q4 24
-158.3%
-206.3%
Q3 24
-151.0%
Q2 24
-186.5%
Q1 24
-280.6%
Net Margin
FBIO
FBIO
HRI
HRI
Q4 25
-24.5%
-331.7%
Q3 25
33.2%
-74.1%
Q2 25
94.4%
-171.4%
Q1 25
-80.6%
-332.8%
Q4 24
-44.7%
-250.3%
Q3 24
-88.0%
Q2 24
-73.5%
Q1 24
-118.3%
EPS (diluted)
FBIO
FBIO
HRI
HRI
Q4 25
$-0.15
$-0.36
Q3 25
$0.11
$-0.03
Q2 25
$0.45
$-0.08
Q1 25
$-0.48
$-0.15
Q4 24
$-0.16
$-0.15
Q3 24
$-0.76
Q2 24
$-0.73
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
HRI
HRI
Cash + ST InvestmentsLiquidity on hand
$79.4M
$550.7M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$437.8M
Total Assets
$185.5M
$1.1B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
HRI
HRI
Q4 25
$79.4M
$550.7M
Q3 25
$86.2M
$432.8M
Q2 25
$74.4M
$67.6M
Q1 25
$91.3M
Q4 24
$57.3M
$30.0M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
HRI
HRI
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
$300.0K
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
HRI
HRI
Q4 25
$49.9M
$437.8M
Q3 25
$55.9M
$486.1M
Q2 25
$43.9M
$90.8M
Q1 25
$22.3M
$26.1M
Q4 24
$22.7M
$16.6M
Q3 24
$21.2M
Q2 24
$17.9M
Q1 24
$23.0M
Total Assets
FBIO
FBIO
HRI
HRI
Q4 25
$185.5M
$1.1B
Q3 25
$181.4M
$550.2M
Q2 25
$159.9M
$152.0M
Q1 25
$178.1M
$104.6M
Q4 24
$144.2M
$109.6M
Q3 24
$127.1M
Q2 24
$145.7M
Q1 24
$164.6M
Debt / Equity
FBIO
FBIO
HRI
HRI
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
0.02×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
HRI
HRI
Operating Cash FlowLast quarter
$-12.5M
$-12.7M
Free Cash FlowOCF − Capex
$-14.3M
FCF MarginFCF / Revenue
-47.6%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
HRI
HRI
Q4 25
$-12.5M
$-12.7M
Q3 25
$-6.1M
$-11.0M
Q2 25
$-27.6M
$-8.4M
Q1 25
$-19.6M
$-6.7M
Q4 24
$-12.9M
$-8.1M
Q3 24
$-20.1M
Q2 24
$-21.8M
Q1 24
$-25.4M
Free Cash Flow
FBIO
FBIO
HRI
HRI
Q4 25
$-14.3M
Q3 25
$-11.1M
Q2 25
$-8.5M
Q1 25
$-6.8M
Q4 24
$-8.1M
Q3 24
Q2 24
Q1 24
FCF Margin
FBIO
FBIO
HRI
HRI
Q4 25
-47.6%
Q3 25
-110.2%
Q2 25
-135.5%
Q1 25
-160.8%
Q4 24
-197.1%
Q3 24
Q2 24
Q1 24
Capex Intensity
FBIO
FBIO
HRI
HRI
Q4 25
5.3%
Q3 25
1.7%
Q2 25
1.5%
Q1 25
4.0%
Q4 24
0.7%
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
FBIO
FBIO
HRI
HRI
Q4 25
Q3 25
-1.04×
Q2 25
-1.78×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIO
FBIO

Segment breakdown not available.

HRI
HRI

Sales Of New Equipment$9.0M30%
Sales Of Parts And Supplies$8.0M27%
Other$7.1M24%
Serviceand Other Revenue$6.0M20%

Related Comparisons